What is it about?
In this study, weighted gene co-expression network analysis (WGCNA) has been used to identify differentially expressed genes in CIS disease and the main pathways associated with it.
Featured Image
Photo by Hal Gatewood on Unsplash
Why is it important?
The new disease-involved pathways may be considered potential therapeutic goals for CIS management in the future.
Read the Original
This page is a summary of: Riboflavin and Histidine Metabolisms Are Two Key Pathways Related
to the Clinically Isolated Syndrome (CIS): A WGCNA-based In silico
Analysis, Current Pharmacogenomics and Personalized Medicine, April 2023, Bentham Science Publishers,
DOI: 10.2174/1875692120666230504114225.
You can read the full text:
Contributors
The following have contributed to this page
